Sleep Disorders Trial, Recruiting NCT06862297 Sponsor: Taipei Medical University WanFang Hospital Condition: Sleep Disorders
Back to Sleep Disorders

Sleep Disorders Trial, Recruiting

NCT06862297
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People between the ages of 20 and 75 years old
  • People who have been referred by a healthcare professional because sleep apnea is suspected, based on signs such as excessive daytime sleepiness, loud snoring, breathing pauses during sleep, or a high-risk result on a standard sleep apnea screening questionnaire
  • People whose healthcare professional has determined that a full overnight sleep study (called polysomnography or PSG) is needed
  • People who are willing to sign a consent form after being informed about what the trial involves, and who are able to understand and follow the study procedures
  • People who agree to allow the research team to review relevant past medical records and include sleep apnea-related health history in the study records

Who may not be able to join:

  • People who are currently using a device to treat sleep apnea — such as a CPAP machine or a mouthguard-type device — and who are unable to sleep safely without it
  • People with significant ongoing breathing conditions, such as chronic obstructive pulmonary disease (COPD), unstable asthma, or other serious respiratory conditions that could affect sleep study results
  • People with unstable heart conditions or who have recently been hospitalised for a heart-related issue
  • People taking medications that affect sleep or muscle tone, such as sedatives or muscle relaxants
  • People with physical features or conditions that may interfere with a small jaw-tracking device being worn during the study, such as significant facial hair, dental appliances, or serious dental problems
  • People with neurological conditions that affect jaw muscle control or that produce symptoms similar to sleep apnea, such as Parkinson's disease or severe neurological effects from a stroke
  • People who have been diagnosed with a psychiatric or psychological disorder under the DSM-IV or DSM-V classification systems, or who have other significant emotional or psychological history
  • People considered unsuitable for the trial for any other reason, as determined by the principal investigator or sleep technician (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 7 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +886-229307930

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Taipei Medical University WanFang Hospital
Registry
ClinicalTrials.gov
Start date
19 September 2024
Est. completion
2 September 2025

Where this trial is recruiting

🇹🇼 Taiwan

Primary endpoints

Baseline Demographic and Anthropometric Data; Apnea-Hypopnea Index (AHI) measured by Polysomnography (PSG); Respiratory Disturbance Index (RDI) measured by Polysomnography (PSG); ECG-Derived Heart Rate Variability (HRV) Parameters

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov